Rege Nephro
regenephro.co.jp
Dialysis & Kidney Care
Regenerative Medicine
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Overview
Rege Nephro is a Japanese biotechnology company developing cell therapies to treat chronic kidney disease using nephron progenitor cells differentiated from induced pluripotent stem (iPS) cells. It is developing nephron progenitor cell-based regenerative products intended to restore nephron function and reduce or eliminate patients' dependence on dialysis. The company targets the large chronic kidney disease patient population in Japan and internationally, aiming to offer a curative alternative to lifelong dialysis through advanced regenerative medicine.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
NVCCVia a fund
Tohoku University Venture PartnersVia a fund
Kyoto University Innovation CapitalVia a fund
JIC Venture Growth InvestmentsVia a fund
Global BrainVia a fund
532 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely